ArticleAnnals of nuclear medicine2026
The anatomical distribution of metabolic tumor burden provides prognostic information beyond whole-body ¹⁸F-FDG PET/CT metrics in de novo metastatic HER2-positive breast cancer.
Ayşegül Aksu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.